Myroides odoratum cellulitis and bacteremia: A case report

Infectious Diseases in Clinical Practice

Volumn 12, Issue 6, 2004, Pages 343-344

  Motwani, Bharat ^a,b   Krezolek, Dorota ^a   Symeonides, Simon ^a   Khayr, Walid ^a,c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Apt 2D ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIUM IDENTIFICATION; CASE REPORT; CELLULITIS; CLINICAL FEATURE; FLAVOBACTERIUM; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MYROIDES ODORATUM; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENICITY; REVIEW; SEPTIC SHOCK;

EID: 8644240963     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000144904.51074.79     Document Type: Review

References (12)

1. Sato K, Fujii T, Okamoto R, et al. Biochemical properties of beta-lactamase produced by Flavobacterium odoratum. Antimicrob Agents Chemother. 1985;27:612-614.
2. Vancanneyt M, Segers P, Torck U, et al. Reclassification of Flavobacterium odoratum (Stutzer 1929) strains to a new genus, Myroides odoratus comb. nov. and Myroides odoratimimus sp. nov. Int J Syst Bacterial. 1996;46:926-932.
3. Strausbaugh LJ, Bachman KH, Sewell DL. Recurrent cellulitis and bacteremia caused by Flavobacterium odoratum. Clin Infect Dis. 1996;22:1112-1113.
4. Green BT, Green K, Nolan PE. Myroides odoratus cellulitis and bacteremia: case report and review. Scand J Infect Dis. 2001;33:932-934.
5. Hsueh PR, Wu JJ, Hsiue TR, et al. Bacteremic necrotizing fascitis due to Flavobacterium odoratum. Clin Infect Dis. 1995;21:1337-1338.
6. Yagci A, Cerikcioglu N, Kaufmann ME, et al. Molecular typing of Myroides odoratimimus (flavobacterium odoratum) urinary tract infections in a Turkish hospital. Eur J Clin Microbiol Infect Dis. 2000;19:731-732.
7. Davis JM, Peel MM, Gillians JA. Colonization of an amputation site by Flavobacterium odoratum after gentamicin therapy. Med J Aust. 1979;29:703-704.
8. Macfarlane DE, Baum-Thureen P, Crandon I. Flavobacterium odoratum ventriculitis treated with IV cefotaxime. J Infect Dis. 1985;11:233-238.
9. Ferrer C, Jakob E, Pastorino G, et al. Right sided bacterial endocarditis due to Flavobacterium odoratum in a patient on chronic hemodialysis. Am J Nephrol. 1995;15:82-84.
10. Blahová J, Hupoková M, Kremery V, et al. Resistance to and hydrolysis of imipenem in nosocomial strains of Flavobacterium meningospeticum. Eur J Clin Microbiol Infect Dis. 1994;13:833.
11. Nordmann P, Mammeri H, Bellais S. Chromosome-encoded beta-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes. Antimicrob Agents and Chemother. 2002;46:3561-3567.
12. McGowan JE, Steinberg JP. Other Gram-negative bacilli. In: Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:2113.